RxDoctor Payments Data

Prabha Long

Family · Elizabethton, TNNPI 1760965628

Payments from drug & device makers

$709in general payments, 2019–2025

Across 43 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$154
  • Exact Sciences$78
  • Johnson & Johnson$76
  • Lilly USA, LLC$54
  • Boehringer Ingelheim$49
  • E.r. Squibb & Sons, L.L.C.$49
  • plus $248 from 13 others

What the payments were for

  • Food & beverage$709100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$709 in reported general payments places this provider in the 55th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$34,002
Medicare patients
97
Services billed
522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide44$49,252
EliquisApixaban36$44,967
JanuviaSitagliptin Phosphate28$37,937
OzempicSemaglutide25$23,877
JardianceEmpagliflozin18$23,719
FarxigaDapagliflozin Propanediol15$18,183
Combivent RespimatIpratropium/Albuterol Sulfate11$11,383
LivaloPitavastatin Calcium13$10,118
PremarinEstrogens, Conjugated17$7,743
SymbicortBudesonide/Formoterol Fumarate26$6,550
Spiriva RespimatTiotropium Bromide12$6,363
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$5,672
Tresiba Flextouch U-100Insulin Degludec12$4,810
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen135$4,182
Omeprazole122$2,835

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$26$52,71053 claims
Lilly USA, LLCMounjaro$54$49,25244 claims
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$49$41,46541 claims
Novo NordiskOzempic$154$23,87725 claims
Kowa Pharmaceuticals America, Inc.Livalo$16$10,11813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,706 family providers in Tennessee.

Other family in Elizabethton

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →